Xponential Fitness Q2 Revenue Drops 13%, Cash Halves, and Material Weaknesses Persist
XPOF sits 31% above its 52-week low of $3.83 on elevated volume (11× avg).
Summary
Xponential Fitness reported a 13% revenue decline and a net loss in Q2 2026, with cash reserves halving and material weaknesses in internal controls still unresolved. The company also disclosed an ongoing strategic review and finalized costly regulatory settlements.
Key Events · Earnings and Guidance · XPOF
-
Revenue Drops 13%, Swings to Loss
Q2 2026 revenue fell to $66.0M from $76.2M a year ago, driven by a 90% collapse in merchandise revenue and a 26% drop in equipment revenue. The company reported a net loss of $4.8M versus a $1.3M profit in Q2 2025.
-
Same-Store Sales Decline Accelerates
Same-store sales fell 7% in Q2 2026, worsening from a 6% decline in Q1 2026, signaling deteriorating franchisee health.
-
Cash Burn Intensifies, Liquidity Tightens
Cash and equivalents dropped to $25.0M from $45.9M at year-end 2025. Operating activities burned $25.7M in H1 2026, and the company drew $10.0M on its revolving credit facility.
-
Material Weaknesses and Ineffective Controls Persist
The company confirmed that material weaknesses in internal controls remain unremediated, and its disclosure controls and procedures were not effective as of June 30, 2026.
Analysis · XPOF · Trade & Services
A deepening crisis is laid bare in Xponential Fitness's Q2 2026 results. Revenue fell 13% year-over-year to $66.0 million, and the company swung to a $4.8 million net loss from a $1.3 million profit a year ago. Same-store sales declined 7%, accelerating from the prior quarter's 6% drop. Cash and equivalents were cut in half to $25.0 million, with $25.7 million in operating cash burn during the first half of 2026. The company still has not fixed its material weaknesses in internal controls, and its disclosure controls remain ineffective. On top of this, the FTC consent order was finalized with a $17.0 million settlement, and the NYAG matter settled for $4.0 million. The company also disclosed an ongoing strategic review, including a potential sale, and warned that recent board and management departures could disrupt governance. This is a critical update that fundamentally alters the risk profile.
At the time of this filing, XPOF was trading at $5.03 on NYSE in the Trade & Services sector, with a market capitalization of approximately $223.7M. The 52-week trading range was $3.83 to $10.29. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.